Mentioned On
Episode Mentions
Pharmaceutical Executive · May 13, 2026
Pharmaceutical Executive Daily: Rigel Pharmaceuticals Enters an Exclusive Global Licensing Agreement with Arvinas and Pfizer for Veppanu
“Co-licensor of Vepanu with Pfizer; receives $70M upfront plus milestone payments and royalties”
PROTAC Technology and Protein DegradationCancer Therapy InnovationGLP-1 Receptor Agonist Therapies
View Analysis